Jefferies Financial Group’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.44M	Buy	196,292 +24,200	+14%	+$538K	0.05%	375
2025 Q4	$4.45M	Buy	172,092 +123,805	+256%	+$2.94M	0.04%	524
2025 Q3	$1.24M	Buy	48,287 +4,695	+11%	+$115K	0.01%	795
2025 Q2	$1.04M	Sell	43,592 -130,700	-75%	-$3.29M	0.02%	725
2025 Q1	$4.33M	Buy	174,292 +75,522	+76%	+$1.81M	0.07%	332
2024 Q4	$1.86M	Buy	98,770 +70,220	+246%	+$1.23M	0.02%	690
2024 Q3	$430K	Sell	28,550 -21,550	-43%	-$368K	0.01%	1023
2024 Q2	$1.43M	Sell	50,100 -2,621	-5%	-$74.6K	0.03%	640
2024 Q1	$1.54M	Sell	52,721 -10,640	-17%	-$327K	0.03%	673
2023 Q4	$2.14M	Buy	63,361 +28,699	+83%	+$840K	0.03%	691
2023 Q3	$1.06M	Buy	34,662 +20,351	+142%	+$734K	0.03%	817
2023 Q2	$573K	Sell	14,311 -13,815	-49%	-$571K	0.01%	1134
2023 Q1	$1.15M	Buy	28,126 +451	+2%	+$17.9K	0.02%	849
2022 Q4	$1.07M	Buy	+27,675	New	+$1.35M	0.02%	849